Related Experiment Video
Updated: Mar 22, 2026

Modeling and Evaluation of Murine Diabetic Cardiomyopathy Model
Published on: November 29, 2024
Myocardial dysfunction and cardiovascular disease in type 2 diabetes
1a Department of Medical Research , Bærum Hospital, Vestre Viken Hospital Trust , Drammen , Norway.
Type 2 diabetes (T2DM) significantly increases heart dysfunction and cardiovascular disease (CVD) risk, often undetected early. A multifactorial approach, not just glucose control, is key for managing these risks in T2DM patients.
Area of Science:
- Cardiology
- Endocrinology
- Metabolic Diseases
Background:
- Type 2 diabetes mellitus (T2DM) is linked to myocardial dysfunction and cardiovascular disease (CVD), with dysfunction potentially affecting 75% of patients.
- Diabetic myocardial dysfunction is often asymptomatic and subclinical, complicating diagnosis due to co-morbidities and lack of standardized criteria.
- Pathophysiology involves hyperglycemia and free fatty acids, leading to heart failure (HF) risk and worse outcomes post-cardiac events.
Purpose of the Study:
- To highlight the high prevalence and diagnostic challenges of myocardial dysfunction in T2DM.
- To emphasize the need for advanced diagnostic tools for early detection of subclinical cardiac changes.
- To discuss the role of T2DM in accelerated atherosclerosis, CAD, and stroke, and the limitations in current diagnostic methods for CAD.
Main Methods:
- Review of existing literature on T2DM, myocardial dysfunction, and cardiovascular disease.
- Analysis of pathophysiological mechanisms linking hyperglycemia, free fatty acids, and cardiac dysfunction.
- Evaluation of current diagnostic challenges and the need for novel biomarkers for CAD detection.
Main Results:
- Myocardial dysfunction is highly prevalent in T2DM but often overlooked due to its asymptomatic nature.
- Accelerated atherosclerosis, driven by inflammation, leads to high rates of CAD and stroke in T2DM patients.
- Current diagnostic tests for CAD in T2DM have limited sensitivity, necessitating new biomarkers.
Conclusions:
- A multifactorial approach targeting multiple cardiovascular risk factors is more effective than solely focusing on glucose lowering for macrovascular events.
- Emerging research suggests this comprehensive strategy may also improve heart failure outcomes in T2DM.
- Improved diagnostic strategies, including sensitive echocardiography and novel biomarkers, are crucial for managing cardiovascular complications in T2DM.
More Related Videos
05:58Mouse Electroacupuncture Fixation Device Fabrication for Electroacupuncture Pretreatment in Diabetic Cardiomyopathy Mouse Model
Published on: April 18, 2025
11:00Assessment of Sarcoplasmic Reticulum Calcium Reserve and Intracellular Diastolic Calcium Removal in Isolated Ventricular Cardiomyocytes
Published on: September 18, 2017
Related Concept Videos
Cardiomyopathy II: Dilated Cardiomyopathy
Diabetes Mellitus: Type 2 and Gestational
Coronary Artery Disease I: Introduction
Cardiomyopathy I: Introduction and Classification
Carbohydrate Metabolism
Starch accounts for approximately 60% of the carbohydrates consumed by humans. Since amylase enzymes cannot function in the stomach's acidic environment, starch can only be digested in the mouth and small intestine. Simple sugars are found naturally in milk and fruits in...
Pathophysiology of Diabetes
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...